are bromantane and Noopept proven cognitive enhancers for healthy people?
both compounds have human records. those records answer narrower questions than healthy cognitive enhancement marketing asks.
verdict: human evidence present, healthy-enhancement claim unproven (disease-specific data / transfer gap)
quick answer
bromantane has older human evidence in asthenic disorders and a ten-person acute healthy-volunteer experiment. Noopept has a small active-comparator study in vascular or post-traumatic cognitive impairment. Neither record establishes durable cognitive enhancement in healthy people.
the evidence
the clinical records are not imaginary. (supported)
Bromantane reduced asthenic symptoms in an older placebo comparison, while Noopept reported disease-specific cognitive improvement against an active comparator.
the population transfer is large. (gap)
A tiny acute healthy-volunteer bromantane experiment and a Noopept impairment study cannot establish durable enhancement in healthy people.
adverse effects and product content stay in the answer. (risk)
The Noopept study reported sleep disturbance, irritability, and blood-pressure increases, and US supplement testing found inaccurate amounts and undeclared drug combinations.
bottom line
human administration is not the same thing as proof for the marketed population and outcome.
scores
- human administration: 62 — both have published clinical exposure
- healthy cognition: 14 — tiny or absent direct outcome evidence
- product identity: 30 — US Noopept supplement testing found major label problems
- transfer gap: 82 — asthenia and brain injury are not healthy enhancement
keep reading
- open bromantane entry — asthenia and healthy-volunteer split
- open Noopept entry — clinical and supplement-testing record
- focus category — outcome-ranked evidence
reptides grades the research record and cites the literature behind every call. research reference only; not medical advice.
